It has been reported that molecular detection of tumour markers such as carcinoembryonic antigen (CEA), cytokeratin 19 (CK-19), cytokeratin 20 (CK-20) is better correlated with peritoneal recurrence and associated with adverse outcomes in patients with GC10,17–19. Here, KRT19 is linked to neoplasm.